|
|
| Enabling Subcutaneous Delivery For Improved Patient Compliance | The ability to administer high doses of biologics subcutaneously offers numerous benefits, including reduced treatment burden, improved patient convenience, and increased adherence to treatment regimens. Discover how Nanoform Biologics’ innovative approach to high-dose subcutaneous delivery of biologics addresses the challenges of traditional SC delivery methods. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ChemOutsourcing 2025 is the leading U.S. conference for small molecule API, peptide, oligonucleotide, and drug development services. Held September 2–5 in Parsippany, NJ, it attracts biotech and pharma buyers seeking CDMO partners. With 100+ global CDMOs, expert panels, and targeted networking, it’s the go-to event for small molecule, peptide, and oligo outsourcing, connecting innovators across the global pharmaceutical supply chain. |
|
|
|
|
By Pooja Sharma, Global Market Insights | The rise of precision medicine like ADCs has created new markets for highly potent API. More suppliers are building out capacity to meet the demand. | |
|
|
|
|
|
|
|
|
|
|
Connect With Pharmaceutical Online: |
|
|
|